These seven companies are among those players well-positioned to leverage the dynamics of the changing spine market.
Technologies used in spine surgery, shifting perspectives on their strategic importance and what could spur mass market adoption.
The collaboration seeks to develop a first-of-kind stimulating/sensing 3D-printed interbody fusion cage.
The company is also approved to provide an Irish logistics hub for the distribution of allograft products in the EU.
Xtant acquired certain assets, including equipment and inventory, used in RTI’s synthetic bone graft business and assumed the lease for the nanOss production facility.
The partnership aims to include Aclarion’s Nociscan surgical decisioning technology within ATEC’s AlphaInformatiX platform to better inform spine surgery.
Spine companies are building commercial strategies and product portfolios that respond to important market drivers.
The completed transaction includes all cervical and lumbar fusion products, including the STALIF technology platform.
PeekMed will launch a solution powered by AI and deep learning technologies that can automatically segment CT scans and X-rays, detect landmarks and create a surgical plan in under a minute.
The merger will integrate Advanced Biologics’ proprietary products into Isto’s growing portfolio of allografts in their Influx line.
The two will co-develop spine surgery applications and co-market the eCential Robotics open platform for robotic surgery in the US.
This collaboration of imaging and visualization seeksk to offer insight into patient anatomy and pave the way for more precise diagnoses and treatment planning.
Argentina and Taiwan are the latest territories to approve STIMULAN as an antibiotic carrier that can be used in bone and soft tissue.
The company’s full porftfolio of silicon nitride spine products are now available at DOD and VA facilities.
Johnson, who has served as interim CEO since March 2023, succeeds Jeffrey Binder, Chairman of Exactech’s Board of Directors.
Trax Surgical is an orthopedic product development and distribution company principally serving the needs of the orthopedic extremities market.
As a pure play orthobiologics entity, OssDsign will focus on Catalyst, an off-the-shelf nanosynthetic bone graft product.
Lima’s solutions include digital innovation and patient-tailored hardware, developed to improve patient outcomes following joint replacement surgery.
Login
Register for a free account
As a guest member you get access to more articles and webinars every month.